About: OKYO Pharma Limited, a clinical-stage ophthalmology company, develops therapies for corneal and anterior diseases in the United Kingdom. Its lead clinical product candidate is urcosimod, which is in Phase 2 clinical trials for the treatment of dry eye disease and neuropathic corneal pain. The company is also developing OK-201 for the treatment of acute and chronic ocular pain. OKYO Pharma Limited was incorporated in 2007 and is headquartered in London, the United Kingdom.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.40 (-4.76%)
OKYO NASDAQ OKYO Pharma Limited
OKYO Pharma Limited share price
Atividade de preço de OKYO
Último preço
$ 1,400
Variação (24h)
-0,07 USD (4,76%)
Volume
13.85K
Volume (média 4 sem.)
-
Abertura
$ 1,46
Variação do dia
$ 1,40 - $ 1,47
Fechamento anterior
$ 1,47
Último negócio
23 Oct, 8:00 pm GMT+0
Atrasado
23 Oct, 8:00 pm GMT+0
OKYO price performance
Atrasado
23 Oct, 8:00 pm GMT+0
quote.marketSignals